Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort
Jonathan E. Golub(GTx (United States)), Neil Martinson(University of the Witwatersrand), Glenda Gray(South African Medical Research Council), James McIntyre(Perinatal HIV Research Unit), Helen Struthers, Richard E. Chaisson(Johns Hopkins University), Nkeko Thsabangu, Mosa Moshabela, Lerato Mohapi, Paul Pronyk(SingHealth Duke-NUS Academic Medical Centre)
Cited by 231
Related Papers
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k